By drawing the ROC curve of the non-small-cell lung cancer group and box plots values with lower and upper value limits of HSP90α and other tumour biomarkers such as CEA, CYFRA21-1, and SCC, it is found that the patients with higher HSP90α are at later stages. This evidence concerns the gene SERPINB3 and non-small cell lung carcinoma.